---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-046717"
form_type: "8-K"
ticker: "HIND"
cik: "0001427570"
company_name: "Vyome Holdings, Inc"
filed_at: "2025-05-09T23:59:59+00:00"
generated_at: "2026-05-22T01:34:21.603362+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# ReShape Lifesciences implements 1-for-25 reverse stock split effective May 9, 2025

## Summary
- Reverse stock split at 1-for-25 ratio effective at trading open on May 9, 2025; each 25 shares become 1.
- Stockholders approved the split at special meeting on April 1, 2025; fractional shares rounded up.
- Authorized shares unchanged; proportional adjustments to warrants, options, and convertible preferred.
- New CUSIP for post-split common stock is 76090R408.

## SEC filing metadata
- accession: 0001104659-25-046717
- form_type: 8-K
- ticker: HIND
- cik: 0001427570
- company_name: Vyome Holdings, Inc
- filed_at: 2025-05-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.03, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1427570/000110465925046717/0001104659-25-046717-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1427570/000110465925046717/tm2514338d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-046717
- JSON: https://secwatch.observer/filing/0001104659-25-046717.json
- Plain text: https://secwatch.observer/filing/0001104659-25-046717.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.